Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Operating Expenses (2016 - 2017)

Historic Other Operating Expenses for KalVista Pharmaceuticals (KALV) over the last 4 years, with Q1 2017 value amounting to -$9.6 million.

  • KalVista Pharmaceuticals' Other Operating Expenses changed N/A to -$9.6 million in Q1 2017 from the same period last year, while for Oct 2017 it was -$9.6 million, marking a year-over-year decrease of 75506.85%. This contributed to the annual value of -$53.4 million for FY2025, which is 4924.99% down from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Other Operating Expenses of -$9.6 million as of Q1 2017.
  • KalVista Pharmaceuticals' Other Operating Expenses' 5-year high stood at $3.8 million during Q4 2014, with a 5-year trough of -$9.6 million in Q1 2017.
  • For the 4-year period, KalVista Pharmaceuticals' Other Operating Expenses averaged around -$855800.0, with its median value being $1000.0 (2016).
  • Examining YoY changes over the last 5 years, KalVista Pharmaceuticals' Other Operating Expenses showed a top increase of 10002.61% in 2015 and a maximum decrease of 10002.61% in 2015.
  • KalVista Pharmaceuticals' Other Operating Expenses (Quarter) stood at $3.8 million in 2014, then plummeted by 100.03% to -$1000.0 in 2015, then surged by 200.0% to $1000.0 in 2016, then tumbled by 956500.0% to -$9.6 million in 2017.
  • Its Other Operating Expenses was -$9.6 million in Q1 2017, compared to $1000.0 in Q4 2016 and $1.5 million in Q1 2016.